Hemodialysis And Peritoneal Dialysis Global Market Report 2023 – By Type (Hemodialysis, Short Term Catheter, Chronic Catheter, Graft, Fistula, Peritoneal Dialysis), By Modality (Conventional, Daily (Day Time, Night Time), By End User (Hospitals, Clinics, And Dialysis Centers, Home Dialysis) – Market Size, Trends, And Global Forecast 2023-2032 

Dialysis devices and equipment are used to filter a patient’s blood by removing waste products such as urea, creatinine, and excess water when kidneys fail or are damaged, dysfunctional, or missing. The main products of the dialysis devices and equipment market are hemodialysis devices and peritoneal dialysis devices. Hemodialysis is a process where a dialysis machine and a special filter called an artificial kidney, or a dialyzer, are used to clean the blood. The various applications involved are serum and blood treatment, virus purification, drug binding studies, and others. The various end-users are hospitals, clinics, ambulatory surgical centers, and home care settings. The global dialysis devices and equipment market is segmented - 1) By Product: Hemodialysis Devices, Peritoneal Dialysis Devices 2) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings 3) By Application: Serum And Blood Treatment, Virus Purification, Drug Binding Studies, Other Applications The global dialysis devices and equipment market size will grow from $4.72 billion in 2022 to $5.01 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global dialysis devices and equipment is expected to grow to $6.12 billion in 2027 at a CAGR of 5.1%. The increasing prevalence of kidney failure is driving the dialysis devices and equipment market. The main purpose of dialysis devices and equipment is to artificially filter the blood to get rid of any toxins in the blood and to prevent such waste products from reaching hazardous levels. Chronic kidney disease (CKD) is a condition in which the kidneys are damaged and cannot filter the blood. According to the National kidney Foundation, in 2021, kidney disease affects 37 million people in the US and 90% of the patients are unaware about it. 2 in 5 adults who had serious kidney disease didn’t know that they had it. Major players in the dialysis devices and equipment market are Fresenius Medical Care AG & Co. KGaA, Baxter International, Nikkiso Co. Ltd., DaVita Inc., B. Braun Avitum AG, NxStage Medical, Asahi Kasei Corporation, Diaverum Deutschland GmbH, Medivators Inc., and Nipro Corporation. Product recalls have been the major restraint in the dialysis devices and equipment market. Product recalls are actions taken by organizations or any regulatory authority like US FDA to remove a product or device from the market. The dialysis devices and equipment are removed from the market when they fail to perform the functions for which they were manufactured. For example, B. Braun Medical Inc. recalls Dialog hemodialysis systems due to defective conductivity sensors. This machine is used in the treatment of chronic kidney disease for patients whose kidneys are no longer healthy enough to filter the blood to get rid of the wastes and excess fluid. Similarly, the Dialyzer, a device by the Fresenius Medical Care group was recalled due to the invalid message shown on the equipment when the Sustained low-efficiency Dialysis (SLED) program is used. The latest trend in the dialysis devices and equipment market is the use of technology to develop innovative products that can enhance functionality. To enhance the quality of the devices, new methods are being developed to speed up the process of filtering blood and improve the overall filtration process. As a result of improved technology products like Revaclear High-Flux Dialyzer by Baxter, which enhances the filtration process of the blood by improving the speed at which the blood is filtered are being developed. Revaclear dialyzers are devices that can help detect renal failure by hemodialysis. With the improvement in technology, innovations in devices are expected to continue. In April 2022, Baxter International received FDA clearance for its ST Set in-hospital dialysis machine. The company had filed an emergency use authorization request back in August 2020. Such approvals by FDA positively impact the global dialysis devices market. In September 2022, W.L. Gore & Associates, a US-based material science company, acquired InnAVasc Medical for an undisclosed amount. The acquisition strengthens the company’s ambition to improve the patients’ lives and providing innovative treatment to them. InnAVasc is a US-based medical technology company developing treatment to ease the dialysis patients. Asia-Pacific was the largest region in the global dialysis devices and equipment market in 2022. North America was the second largest market in dialysis devices and equipment market report. The regions covered in the dialysis devices and equipment analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dialysis devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The dialysis devices and equipment market consist of sales of instruments such as dialyzers, dialysis pumping machines, blood pumps, catheters, and tubing kits that are used for dialysis. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dialysis devices and equipment market research report is one of a series of new reports from The Business Research Company that provides dialysis devices and equipment market statistics, including dialysis devices and equipment industry global market size, regional shares, competitors with a dialysis devices and equipment market share, detailed dialysis devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dialysis devices and equipment industry. This dialysis devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular grafts are used to repair the diseased or blocked blood vessel during the surgical procedure called vascular graftsing or vascular bypass. Vascular grafting is performed to bypass a partial or complete blockage in an artery by reconnecting the blood vessels. This process improves the blood flow by redirecting blood from one area of the body to another. The main products of the vascular grafts market are hemodialysis access graft, endovascular stent graft, peripheral vascular grafts, and coronary artery bypass graft. Endovascular stent graft refers to the method of minimally invasive method that is used to treat an aortic aneurysm and is performed to know the presence of abdominal pain, symptoms for the disease, and also for the size of the aneurysm. The various raw materials are polyester grafts, ePTFE, polyurethane grafts, and biosynthetic grafts. The various applications of vascular grafts are coronary artery disease, aneurysm, vascular occlusion, and renal failure that are used by end-users such as hospitals and ambulatory surgical centres. The global vascular grafts market is segmented - 1) By Product: Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft 2) By Raw Material: Polyester Grafts, ePTFE, Polyurethane Grafts, Biosynthetic Grafts 3) By Application: Coronary Artery Disease, Aneurysm, Vascular Occlusion, Renal Failure 4) By End-User: Hospitals, Ambulatory Surgical Centers The global vascular grafts market size grew from $2.96 billion in 2022 to $3.21 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global vascular grafts is expected to grow from $4.37 billion in 2027 at a CAGR of 8.1%. The rising prevalence of vascular diseases is driving the growth of the global vascular grafts market. According to a study by the National Center for Biotechnology Information in the US, cardiovascular diseases are the leading cause of death in the world and according to the American Heart Association (AHA), the overall prevalence of myocardial infarction in the US was around 7.9 million per year, while the estimated annual incidence of a heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. According to a study by NHS Inform, a national health service of Scotland, every year around 20,000 coronary bypass grafts are carried out in England. Therefore, the high prevalence of vascular diseases is anticipated to drive the global vascular grafts market. Major players in the vascular grafts market are B. Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic PLC., Getinge, Terumo Medical Corporation, and Gore Medical. The high cost of medical treatment and complications related to prosthetic grafts are expected to restrain global vascular graftss market growth. The cost of the CABG (coronary artery bypass graft) surgery is very high in western countries. For instance, in the US, the average cost of coronary artery bypass surgery is $40,000, which varies widely by region and facility. Moreover, several complications are associated with prosthetic grafts such as disruption of an infected anastomotic suture line due to rupture or pseudoaneurysm formation, sepsis, amputation, thromboembolism, chances of reinfection due to vascular graftss reconstruct, enteric fistulae, the spread of bacterial infection to other sites, and death. Thus, high treatment costs and complications related to prosthetic grafts are expected to restrain the market growth. Companies in the vascular grafts market are increasingly investing in technological advances for the development of innovative vascular graftss, including customization of vascular graftss. For instance, RelayPro, a thoracic stent graft system recently launched by Terumo Aortic, is a low-profile device designed for patients with smaller access vessels in the treatment of thoracic endovascular aortic repair (TEVAR). It offers a broad range of diameters, lengths, tapers, and proximal configurations to the physicians. Both bare stent and non-bare stent (NBS) versions are available for this device and they can be customized to meet the patient’s specific anatomical needs. In June 2020, LeMaitre Vascular, a US-based medical device company, acquired Artegraft for $90 million. The acquisition the company expected to extend its product line with Artegraft’s innovative products and better serve the customers’ needs. Artegraft is a New Jersey-based seller of vascular graftss. North America was the largest region in the vascular grafts market in 2022. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the vascular grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The vascular graftss market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The vascular grafts market research report is one of a series of new reports from The Business Research Company that provides vascular grafts market statistics, including vascular grafts industry global market size, regional shares, competitors with a vascular grafts market share, detailed vascular grafts market segments, market trends and opportunities, and any further data you may need to thrive in the vascular grafts industry. This vascular grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global medical equipment is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the growth of the medical equipment market during the forecast period. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical equipment market data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market share. The regions covered in the medical equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the medical equipment market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified medical equipment market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the medical equipment market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global medical equipment market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, medical equipment market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Blood group typing is a method that tells the type of blood a person has, and it is done so that a person can safely donate blood or receive a blood transfusion. The main types of blood group typing are antibody screening, cross-matching tests, ABO tests, antigen typing and human leukocyte antigen (HLA) typing. The antibody screening tests are performed in a clinical laboratory or blood bank is done to detect the presence of unexpected antibodies, like alloantibodies in the serum to antigens of the non-ABO blood group system. Cross-matching tests are performed before a blood transfusion as part of blood compatibility testing. Human leukocyte antigen (HLA) typing is a kind of genetic test used to identify certain individual variations or proteins in the immune system. It is often used to match patients and donors for bone marrow or cord blood transplants. ABO tests are done to evaluate the blood type of a person out of four types, which are A, B, AB, or O. Antigen tests are immunoassays that are used to detect the presence of a specific viral antigen and are commonly used in the diagnosis of respiratory pathogens, including influenza viruses and respiratory syncytial virus. The products that are used for blood group typing are instruments, reagents, and kits, and the techniques that are used are serology tests, and molecular tests. Blood group typing is used in hospital-based laboratories, independent laboratories, and blood banks. The global blood group typing market is segmented - 1) By Test Type: Antibody Screening, Cross-Matching Tests, ABO Tests, Antigen Typing, HLA Typing 2) By Product: Instruments, Reagents And Kits 3) By Techniques: Serology Tests, Molecular Tests 4) By End User: Hospital Based Laboratories, Independent Laboratories And Blood Banks The global blood group typing market size grew from $2.4 billion in 2022 to $2.7 billion in 2023 at a compound annual growth rate (CAGR) of 12.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the blood group typing is expected to grow to $4.29 billion in 2027 at a CAGR of 12.2%. The increase in number of blood donations and transfusions drove the blood group typing market during the historic period. Different non-profit organizations, government organizations and other agencies are emphasizing the importance of blood donations and transfusions and spreading awareness through various campaigns. An increase in blood donations increased the demand for blood group typing so that the donor can know what type of blood they have. For instance, according to a report by the WHO in 2022, in high-income nations, which are home to 16% of the world's population, blood donations account for 40% of the 118.5 million donations that are made worldwide. Moreover, children under the age of five receive up to 54% of blood transfusions in low-income nations, compared to patients over 60 who receive up to 76% of transfusions in high-income countries. The increase in the number of blood donations and transfusions thereby contributed to the growth of the blood typing market. Major players in the the blood group typing market are Grifols, Bio-Rad Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Quotient, BAG Health Care GmbH, AXO Science, Agena Bioscience, Merck KGaA, Beckman Coulter Inc., Sucuri Inc., Rapid Labs, AXO Science, Day Medical SA, and Novacyt Group. Technological advancements such as automated technologies for blood typing gaining traction in the blood group typing market. Major companies in the market are focusing on introducing new types of tests based on innovative techniques that offer results in low turn-around time, with improved accuracy and efficiency. In September 2021, Ortho Clinical Diagnostics, a US-based in vitro diagnostics company, launched Immediate Spin Crossmatch (ISXM). ISXM is a serological test used in blood transfusions to identify ABO blood type mismatch between donor red blood cells and receiver serum or plasma. This new menu feature expands Ortho's complete automated testing offering with the addition of ISXM. In October 2020, Calibre Scientific, a provider of life science reagents, tools, instruments?and other consumables to the lab research, diagnostics, industrial and biopharmaceutical communities, acquired Lorne Laboratories for an undisclosed amount. The acquisition will support the Calibre diagnostics division and expand the expertise of the company. Lorne Laboratories is a speciality manufacturer of blood grouping reagents and diagnostic test kits. North America was the largest region in the blood group typing market in 2022. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the blood group typing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the blood group typing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The blood group typing market consists of sale of serology reagents, gel systems, lateral flow rapid technology, and blood group genotyping products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The blood group typing market research report is one of a series of new reports from The Business Research Company that provides blood group typing market statistics, including blood group typing industry global market size, regional shares, competitors with a blood group typing market share, detailed blood group typing market segments, market trends and opportunities, and any further data you may need to thrive in the blood group typing industry. This blood group typing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Patient blood management is a patient-focused, evidence-based and systematic approach to optimize care of patients, who might need a blood transfusion, by optimizing patients’ blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions. The patient blood management is segmented by product into instruments, accessories, reagents and kits, software. The patient blood management kits are used to manage the patient’s blood. It is also segmented by component into plasma, whole blood, and red blood cells that are used for applications such as hospitals, clinics, and others. The global patient blood management market is segmented - 1) By Product: Instruments, Accessories, Reagents And Kits, Softwares 2) By Component: Plasma, Whole Blood, Red Blood Cells 3) By Application: Hospital, Clinic, Other Applications The global patient blood management market size grew from $12.82 billion in 2022 to $13.83 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global patient blood management is expected to grow from $17.42 billion in 2027 at a CAGR of 6.0%. The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents. According to the Centers for Disease Control and Prevention, in 2021, the caesarean birth rate was 32.1% of all the births. Increased number of accidents, trauma cases, and surgical procedures resulted in increased demand for blood, and its products are driving the market. Major players in the patient blood management market report are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, Kaneka Corporation, and Bio-Rad Laboratories Inc. The high cost associated with automated systems is expected to limit the growth of the global patient blood management market. Costs associated with an increasing regulatory requirement, infection testing, and hospital administration, which include initial project costs, personnel salaries, costs of equipment, outside resources, and ongoing project costs make automation expensive. According to the Researchgate, in 2022, the expected cost of transfusion of one unit of red cells is US$ 600–$1200. The high economic cost of automation is therefore expected to hamper the market growth. HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss. Clinicians can economically collect sterile, anticoagulated blood without any need for specialized resources. By this, the upfront shed blood collection cost decreases, allogenic transfusions can be avoided with improved outcomes such as decreased patient mortality, low incidence of infections, and reduced risk of multi-organ failure. North America was the largest region in the patient blood management market in 2022. Western Europe was the second largest region in the patient blood management market share. The regions covered in the patient blood management market analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The patient blood management market research report is one of a series of new reports from The Business Research Company that provides patient blood management market statistics, including patient blood management industry global market size, regional shares, competitors with a patient blood management market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the patient blood management industry. This patient blood management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening. The main types of blood transfusion diagnostics are instruments and kits, reagents, and others. The blood transfusion diagnostic kits are used to collect and transfuse blood. The technologies involved in blood transfusion diagnostics are western blot, ELISA, nucleic acid amplification, fluorescence assay, and rapid test that are used for various applications such as blood grouping and disease screening. The end-users involved are hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The global blood transfusion diagnostics market is segmented - 1) By Type: Instruments and Kits, Reagents, Other Types 2) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies 3) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test 4) By Application: Blood Grouping, Disease Screening The blood transfusion diagnostics market size grew from $3.65 billion in 2022 to $3.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of blood transfusion diagnostics is expected to grow from $5.68 billion in 2027 at a CAGR of 9.3%. Patients undergoing surgical procedures need a blood transfusion to replace the lost blood during the procedure. Blood transfusion diagnostics are used during the procedures to screen the blood before transferring it to the patient and will otherwise increase the incidence of infectious disease. According to an article published in the US National Library of Medicine, National Institutes of Health, approximately 310 million surgeries are being performed each year. This increase in the number of procedures will thereby drive the need for blood transfusion diagnostics. Major players in the blood transfusion diagnostics market are BAG Health Care GmbH, Grifols, Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., and Beckman Coulter Inc. Developing and underdeveloped countries lack adequate blood banks, proper medical equipment for blood transfusion, adequate conditions for the storage of blood, and low supply for the high demand of blood. Hospitals are not equipped with proper amenities that help provide hygienic and safe transfusions. For example, according to research conducted by India Spend, around 1.18 million units of blood were wasted during storage in the form of discoloration, bacterial contamination, and expiry due to outdating. The poor infrastructure hampers the growth of the blood transfusion diagnostic market. The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency and reduce the turnaround time of the results. NAT is a technique that helps detect a particular nucleic acid, virus, or bacteria that acts as a pathogen in blood, tissue, or urine. NAT is highly sensitive and specific for viral nucleic acids and amplifies the region of targeted viral DNA and detects them earlier than the other traditional methods and narrows the period of infectious diseases. For example, XCRP Diagnostic Inc. and Luminex Corporations entered into a licensing agreement of XCR Diagnostic's Xtreme Chain Reaction Nucleic Acid Amplification Technology. In this deal, Luminex got the exclusive rights to use the XCR Diagnostic's NAAT technology for their future molecular diagnostic portfolio. The blood transfusion diagnostics market is highly regulated by governing bodies such as USFDA (the USA Food and Drug Administration), and the Medicines and Healthcare products Agency (MHRA). For instance, the manufacturers and service providers in the USA must comply with the Center for Biologics Evaluation and Research (CBER) Regulations that have been published in the first chapter title 21 of the Code of Federal Regulations (CFR). Part 600 of CFR 21 primarily focuses on the established standards like retention samples conditions, temperature to be maintained during shipment, sterilization of equipment, and role and duties of the inspector to inspect the laboratories. The regulation also allows the manufacturer to report any kind of deviation of their product from their intended purpose. North America was the largest region in the blood transfusion diagnostics market in 2022. Western Europe was the second largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the blood transfusion diagnostics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The blood transfusion diagnostics market research report is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An intravascular catheter is a device typically comprised of a hollow fibre through which blood flows and an immunoisolating membrane separates the transplanted cells from the blood. The intravascular catheters are used for the administration of fluids, medication, blood products, and nutrition, which typically goes into a large vein in the arm or chest. The main intravascular catheter products include short PIVC and integrated/closed PIVC. Short peripheral intravenous catheters (PIVC) are less than or equal to 3 inches in length and are used for intravenous medication and are predominantly inserted in general wards. The different intravascular catheter applications include oncology, gastroenterology, renal disease, infectious diseases and other applications which are used by end-users including hospitals, clinics, ambulatory surgical center and homecare. The global intravascular catheters market is segmented – 1) By Product: Short PIVC, Integrated/Closed PIVC 2) By Application: Oncology, Gastroenterology, Renal Disease, Infectious Diseases, Other Applications 3) By End-Use: Hospitals, Clinics, Ambulatory Surgical Center, Homecare The global intravascular catheters market size grew from $5.9 billion in 2022 to $6.66 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of intravascular catheters is expected to grow to $10.32 billion in 2027 at a CAGR of 11.6%. The rising hospitalization rate owing to the high prevalence of chronic diseases is driving the growth of the intravascular catheters market. Globally, the prevalence of chronic illnesses and ailments is rising. Intravascular catheters are used for taking samples for tests and fluids, nutrients, and blood intake during the treatment of chronic diseases. According to an estimation by a German healthcare company, Fresenius Medical Care, the number of people suffering from chronic kidney failure is expected to increase from 3.7 million patients in 2020 to 4.9 million by 2025. Therefore, the rising hospitalization rate owing to the high prevalence of chronic diseases is expected to propel the growth of the intravascular catheters market over the coming years. Major players in the intravascular catheters market are Cook Medical, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc., Johnson & Johnson, McKesson Medical Surgical Inc., Terumo Corporation, Abbott Laboratories Inc., Boston Scientific Corp., Getinge AB, Coloplast Corp., Cardinal Health, Conavi Medical, Infraredx Inc., BD, MAQUET Holding BV & Co KG, Vitality Medical, BBraun, Koninklijke Philips NV, Lumend Corporation, COVIDien Ag, Acist Medical Systems, Biotronic SE, & COKG, Biosense Webster Inc., Cordis, QX Medical and Teleflex Corporated. The product innovations are a key trend gaining popularity in the intravascular catheters market. Major players in the intravascular catheters market are focusing on innovation of new products with advanced features to strengthen their position. For instance, in July 2022, B. Braun Medical Inc., a German-based medical and pharmaceutical device manufacturing company, introduced Introcan Safety 2 IV Catheter with one-time blood control making IV access safer for the clinician by lowering the danger of blood exposure and needle stick accidents. Furthermore, in March 2022, Shockwave Medical Inc., a firm that creates and sells medical devices, introduced the Shockwave M5+ catheter is particularly made to treat calcified lesions in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries in the lower limbs that are otherwise difficult to treat. In January 2021, Prunus Technology Co., Ltd., a Shenzhen-based developer and manufacturer of various medical equipment, acquired Biosensors International Group, Ltd for an undisclosed amount. Through this acquisition, Prunus Technology expanded into central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters and other medical consumables. Biosensors International Group, Ltd. is a Singapore-based company specializing in the critical care consumables business. North America was the largest region in the intravascular catheters market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular catheters market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the intravascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The intravascular catheters market consists of sales of pulmonary artery catheters and pacing wires. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The intravascular catheters market research report is one of a series of new reports from The Business Research Company that provides intravascular catheters market statistics, including intravascular catheters industry, global intravascular catheters market size, regional shares, competitors with an intravascular catheters market share, detailed intravascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular catheters industry. This intravascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Peripheral vascular devices and equipment are used to treat peripheral vascular diseases which are slow and progressive blood circulation disorders caused by blockages, narrowing, or spasms in blood vessels outside the heart and brain including arteries and veins. The main types of peripheral vascular devices and equipment are peripheral vascular stents, percutaneous transluminal angioplasty balloons, catheters, PTA guide wires, atherectomy devices, chronic total Occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. The catheter is a tubular medical device for insertion into canals, vessels, passageways, or body cavities to permit injection or withdrawal of fluids or to keep a passage open. The applications involved are the treatment of peripheral blood vessels damaged and the treatment of peripheral blood vessels blockage. The various end-users are hospital applications and clinic applications. The global peripheral vascular devices and equipment market is segmented - 1) By Type: Peripheral vascular stents, Percutaneous transluminal angioplasty balloons, Catheters, PTA guide wires, Atherectomy devices, Chronic total acclusion devices, Aortic stents, Synthetic surgical grafts, Embolic protection devices, Inferior vena cava filters 2) By End User: Hospital applications, Clinic applications, 3) By Application: Treatment of Peripheral Blood Vessels Damaged, Treatment of Peripheral Blood Vessels Blockage The global peripheral vascular devices and equipment market size will grow from $7.77 billion in 2022 to $8.27 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global peripheral vascular devices and equipment is expected to grow to $10.04 billion in 2027 at a CAGR of 5.0%. The peripheral vascular devices and equipment market is driven by the rising number of people with peripheral artery diseases. Peripheral artery diseases are caused when arteries in the human body are blocked by plaque consisting of fats, cholesterol, and other substances restricting their blood flow to important organs. Lower extremity peripheral artery disease (PAD) affects >230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes (other cardiovascular diseases such as coronary heart disease and stroke and leg outcomes such as amputation. The disease is different in younger populations; but, the incidence rises sharply, with over 20% of people over 80 years old having PAD. According to the Center for Disease Control and Prevention (CDC), approximately 8.5 million people in the USA are suffering from peripheral artery diseases, of which 12-20% are aged above 60 years. Major players in the peripheral vascular devices and equipment market report are Medtronic, Boston Scientific Corporation, Abbott, Cook group, Angiomed GmbH & Co., Medizintechnik KG, Terumo Corporation, ENDOLOGIX Inc., Bolton medical Inc., and JOTEC. Stringent approval processes, product recalls and failures act as a restraint to the peripheral vascular devices and equipment market. Product recalls and failures potentially affect the brand image of the companies within this market. According to the US Food and Drug Administration (FDA), a product recall is made to perform corrective actions or prevent hazardous effects to patients. For instance, in January 2022, Medtronic was instructed to recall its artery-clearing HawkOne System due to reported injuries. To reduce incidences associated with the peripheral devices and ensure that the devices are safe and have the least adverse reactions, FDA is restricting devices for use, sending field safety notices, and making product recall to correct the devices. These stringent approval processes and regulatory policies may impact the peripheral vascular devices and equipment market. Bio-absorbable stents are gaining popularity in the peripheral vascular devices and equipment market to eliminate thrombogenic risk factors and enhance clinical applicability. Bio-absorbable stents are made of natural soluble materials that disappear after insertion and eliminate the risk of late stent thrombosis. They help in protecting the body from inflammation or reduced blood flow due to late-stent thrombosis (a condition where the stent used for treatment stays inside the body for a prolonged period). Companies in this market are increasing their focus on developing and commercializing bio-absorbable stents. For instance, in 2020, Boston Scientific is demanded to start its Synergy Megatron bioabsorbable polymer coronary stent system. It is intended for large proximal vessels, including over main, bifurcations, and ostial lesions. It is made in 3.5 mm to 5.0 mm diameters. It owns enhanced strength and the capacity to create tapered vessels. In January 2022, the U.S Food and Drug Administration issued notice to Medtronic plc for Class I medical device recall for its HawkOne System for clearing out clogged arteries. The notice was issue after certain instances of injuries were reported. In September 2021, Boston Scientific, a US-based manufacturer of medical devices acquired Devoro Medical, Inc for an undisclosed amount. This acquisition of devoro medical inc will add the WOLF platform and advances efforts to ensure physicians have the right tools to improve procedural efficiencies. Devoro Medical, Inc., is a US-based manufacturer of medical technology. North America was the largest region in global peripheral vascular devices and equipment market in 2022. Western Europe was the second-largest region in global peripheral vascular devices and equipment market share. The regions covered in the peripheral vascular devices and equipment market analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the peripheral vascular devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, and Australia. The peripheral vascular devices and equipment market consist of sales of peripheral vascular stents, percutaneous transluminal angioplasty balloons, PTA drug-eluting balloons, embolic protection devices, inferior vena cava filters, Aortic stent-grafts, synthetic surgical drafts, and peripheral guide wires. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The peripheral vascular devices and equipment market research report is one of a series of new reports from The Business Research Company that provides peripheral vascular devices and equipment market statistics, including peripheral vascular devices and equipment industry global market size, regional shares, competitors with a peripheral vascular devices and equipment market share, detailed peripheral vascular devices and equipment market segments, peripheral vascular devices and equipment market trends and opportunities, and any further data you may need to thrive in the peripheral vascular devices and equipment industry. This peripheral vascular devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.